Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Despite slow progress, bispecifics generate buzz. Nat Biotechnol 34, 1215–1217 (2016). https://doi.org/10.1038/nbt1216-1215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1216-1215
- Springer Nature America, Inc.
This article is cited by
-
The promise and challenges of immune agonist antibody development in cancer
Nature Reviews Drug Discovery (2018)
-
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
Current Hematologic Malignancy Reports (2018)